251 related articles for article (PubMed ID: 17260107)
1. Assessment of clinical outcome in patients with esophageal squamous cell carcinoma using TNM classification score and molecular biological classification.
Takeno S; Noguchi T; Takahashi Y; Fumoto S; Shibata T; Kawahara K
Ann Surg Oncol; 2007 Apr; 14(4):1431-8. PubMed ID: 17260107
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of cyclin B1 in patients with esophageal squamous cell carcinoma.
Takeno S; Noguchi T; Kikuchi R; Uchida Y; Yokoyama S; Müller W
Cancer; 2002 Jun; 94(11):2874-81. PubMed ID: 12115375
[TBL] [Abstract][Full Text] [Related]
3. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
4. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
5. Developing an appropriate staging system for esophageal carcinoma.
Kunisaki C; Akiyama H; Nomura M; Matsuda G; Otsuka Y; Ono HA; Shimada H
J Am Coll Surg; 2005 Dec; 201(6):884-90. PubMed ID: 16310691
[TBL] [Abstract][Full Text] [Related]
6. Dukes' classification as a prognostic factor in patients with squamous cell carcinoma of the thoracic esophagus undergoing combined-modality treatment.
Dabrowski A; Skoczylas T; Ciechański A; Wallner G; Zinkiewicz K; Cwik G; Górczyński R; Borowski A
Med Sci Monit; 2006 Oct; 12(10):CR409-15. PubMed ID: 17006399
[TBL] [Abstract][Full Text] [Related]
7. Significance of cyclin B1 expression as an independent prognostic indicator of patients with squamous cell carcinoma of the esophagus.
Nozoe T; Korenaga D; Kabashima A; Ohga T; Saeki H; Sugimachi K
Clin Cancer Res; 2002 Mar; 8(3):817-22. PubMed ID: 11895914
[TBL] [Abstract][Full Text] [Related]
8. Reduced expression of p63 has prognostic implications for patients with esophageal squamous cell carcinoma.
Takahashi Y; Noguchi T; Takeno S; Kimura Y; Okubo M; Kawahara K
Oncol Rep; 2006 Feb; 15(2):323-8. PubMed ID: 16391849
[TBL] [Abstract][Full Text] [Related]
9. CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma.
Sano A; Kato H; Sakurai S; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Nakajima T; Kuwano H
Ann Surg Oncol; 2009 Feb; 16(2):506-14. PubMed ID: 19050962
[TBL] [Abstract][Full Text] [Related]
10. Significant host- and tumor-related factors for predicting prognosis in patients with esophageal carcinoma.
Ikeda M; Natsugoe S; Ueno S; Baba M; Aikou T
Ann Surg; 2003 Aug; 238(2):197-202. PubMed ID: 12894012
[TBL] [Abstract][Full Text] [Related]
11. alpha-catenin is a significant prognostic factor than E-cadherin in esophageal squamous cell carcinoma.
Setoyama T; Natsugoe S; Okumura H; Matsumoto M; Uchikado Y; Yokomakura N; Ishigami S; Aikou T
J Surg Oncol; 2007 Feb; 95(2):148-55. PubMed ID: 17262732
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 amplification as a new predictive classification for squamous cell carcinoma of the esophagus, adding gene information.
Shinozaki H; Ozawa S; Ando N; Tsuruta H; Terada M; Ueda M; Kitajima M
Clin Cancer Res; 1996 Jul; 2(7):1155-61. PubMed ID: 9816282
[TBL] [Abstract][Full Text] [Related]
13. Reduced axin protein expression is associated with a poor prognosis in patients with squamous cell carcinoma of esophagus.
Li AF; Hsu PK; Tzao C; Wang YC; Hung IC; Huang MH; Hsu HS
Ann Surg Oncol; 2009 Sep; 16(9):2486-93. PubMed ID: 19582507
[TBL] [Abstract][Full Text] [Related]
14. Cytokeratin 7 is a predictive marker for survival in patients with esophageal squamous cell carcinoma.
Oue N; Noguchi T; Anami K; Kitano S; Sakamoto N; Sentani K; Uraoka N; Aoyagi K; Yoshida T; Sasaki H; Yasui W
Ann Surg Oncol; 2012 Jun; 19(6):1902-10. PubMed ID: 22203179
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of activated Akt expression in oral squamous cell carcinoma.
Lim J; Kim JH; Paeng JY; Kim MJ; Hong SD; Lee JI; Hong SP
J Clin Pathol; 2005 Nov; 58(11):1199-205. PubMed ID: 16254112
[TBL] [Abstract][Full Text] [Related]
16. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
Miyazaki T; Kato H; Faried A; Sohda M; Nakajima M; Fukai Y; Masuda N; Manda R; Fukuchi M; Ojima H; Tsukada K; Kuwano H
Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
[TBL] [Abstract][Full Text] [Related]
17. Correlation between RhoA overexpression and tumour progression in esophageal squamous cell carcinoma.
Faried A; Nakajima M; Sohda M; Miyazaki T; Kato H; Kuwano H
Eur J Surg Oncol; 2005 May; 31(4):410-4. PubMed ID: 15837049
[TBL] [Abstract][Full Text] [Related]
18. Staging of esophageal carcinoma: length of tumor and number of involved regional lymph nodes. Are these independent prognostic factors?
Bollschweiler E; Baldus SE; Schröder W; Schneider PM; Hölscher AH
J Surg Oncol; 2006 Oct; 94(5):355-63. PubMed ID: 16967455
[TBL] [Abstract][Full Text] [Related]
19. [Tumor biologic prognostic parameters in T1N0M0 squamous cell carcinoma of the oral cavity].
Welkoborsky HJ; Gluckman JL; Jacob R; Bernauer H; Mann W
Laryngorhinootologie; 1999 Mar; 78(3):131-8. PubMed ID: 10226980
[TBL] [Abstract][Full Text] [Related]
20. Prognostic role of PGE2 receptor EP2 in esophageal squamous cell carcinoma.
Kuo KT; Wang HW; Chou TY; Hsu WH; Hsu HS; Lin CH; Wang LS
Ann Surg Oncol; 2009 Feb; 16(2):352-60. PubMed ID: 19050969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]